Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies.
剂量调整的 EPOCH-利妥昔单抗联合氟达拉滨可有效帮助淋巴系统恶性肿瘤患者过渡到低强度异基因造血干细胞移植
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2011.37.0296
Salit Rachel B, Fowler Daniel H, Wilson Wyndham H, Dean Robert M, Pavletic Steven Z, Dunleavy Kieron, Hakim Frances, Fry Terry J, Steinberg Seth M, Hughes Thomas E, Odom Jeanne, Bryant Kelly, Gress Ronald E, Bishop Michael R